Effects of 6 Weeks of Therapy with Oral Doses of ICI 204,219, a Leukotriene D4 Receptor Antagonist, in Subjects with Bronchial Asthma. ACCOLATE Asthma Trialists Group

Overview of attention for article published in American Journal of Respiratory & Critical Care Medicine, September 1994

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (94th percentile)
High Attention Score compared to outputs of the same age and source (82nd percentile)

Mentioned by

twitter: 1 X user
patent: 7 patents

guideline: 3 clinical guideline sources

Readers on

mendeley: 18 Mendeley

So far, Altmetric has seen 7 patents that reference this research output.

Compounds to inhibit or augment an inflammatory response

Grant US-8481558-B2

United States of America

09 Jul 2013

Methods to inhibit or augment an inflammatory response

Grant US-7989466-B2

United States of America

02 Aug 2011

Compounds and methods to inhibit or augment an inflammatory response

Grant US-7700087-B2

United States of America

20 Apr 2010

Compounds and methods to inhibit or augment an inflammatory response

Grant US-7238711-B1

United States of America

03 Jul 2007

This page shows the most recent patents that mention this research output. Click here to find out how to access more activity, including 3 additional patents.